B7-H3 Expression in Breast Cancer and Brain Metastasis
Brain metastasis is a significant challenge for some breast cancer patients, marked by its aggressive nature, limited treatment options, and poor clinical outcomes. Immunotherapies have emerged as a promising avenue for brain metastasis treatment. B7-H3 (CD276) is an immune checkpoint molecule invol...
Main Authors: | Vaibhavi Joshi, Kate Beecher, Malcolm Lim, Andrew Stacey, Yufan Feng, Parmjit S. Jat, Pascal H. G. Duijf, Peter T. Simpson, Sunil R. Lakhani, Amy E. McCart Reed |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-04-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/25/7/3976 |
Similar Items
-
NDRG1 is a prognostic biomarker in breast cancer and breast cancer brain metastasis
by: Vaibhavi Joshi, et al.
Published: (2024-03-01) -
NDRG1 in Cancer: A Suppressor, Promoter, or Both?
by: Vaibhavi Joshi, et al.
Published: (2022-11-01) -
B7H3 As a Promoter of Metastasis and Promising Therapeutic Target
by: Peixin Dong, et al.
Published: (2018-07-01) -
Clinicopathological features and prognostic value of CD276 expression in breast cancer: A meta-analysis
by: Hang Su, et al.
Published: (2023-11-01) -
Ligand Installation to Polymeric Micelles for Pediatric Brain Tumor Targeting
by: Takayoshi Watanabe, et al.
Published: (2023-04-01)